Back
iShares MSCI All Country Asia ex Jpn ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
46
AAXJ
iShares MSCI All Country Asia ex Jpn ETF
Last Price:
74.26
Seasonality Move:
1.52%
Buy
58
SRPT
Sarepta Therapeutics
Last Price:
133.49
Seasonality Move:
14.88%
Sell
46
iShares MSCI All Country Asia ex Jpn ETF (AAXJ)
is a Sell
Is iShares MSCI All Country Asia ex Jpn ETF a Buy, Sell or Hold?
- The current iShares MSCI All Country Asia ex Jpn ETF [AAXJ] share price is $74.20. The Score for AAXJ is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- AAXJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $133.34. The Score for SRPT is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AAXJ Stock Price Chart
What is iShares MSCI All Country Asia ex Jpn ETF's stock price today?
-
The iShares MSCI All Country Asia ex Jpn ETF share price today is $74.20
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AAXJ is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $133.34
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
AAXJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.79 | Sell |
Relative Strength Index (14 RSI): | 42.93 | Sell |
Chaikin Money Flow: | 536966 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.85 - 76.91) | Sell |
Bollinger Bands (100): | (71.28 - 77.6) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.78 | Buy |
Relative Strength Index (14 RSI): | 63.54 | Buy |
Chaikin Money Flow: | -725343 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (110.85 - 129.81) | Buy |
Bollinger Bands (100): | (119.21 - 141.67) | Buy |
AAXJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 74.09 | Buy |
20-day SMA: | 75.02 | Sell |
50-day SMA: | 76.93 | Sell |
200-day SMA: | 71.94 | Buy |
8-day EMA: | 74.14 | Buy |
20-day EMA: | 74.87 | Sell |
50-day EMA: | 75.41 | Sell |
200-day EMA: | 72.47 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 119.83 | Buy |
20-day SMA: | 118.14 | Buy |
50-day SMA: | 122.33 | Buy |
200-day SMA: | 130.09 | Buy |
8-day EMA: | 123.82 | Buy |
20-day EMA: | 120.48 | Buy |
50-day EMA: | 122.96 | Buy |
200-day EMA: | 126.17 | Buy |
iShares MSCI All Country Asia ex Jpn ETF Earnings Growth & AAXJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.75 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $7.74 per share.
iShares MSCI All Country Asia ex Jpn ETF Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |